Treatment of acute promyelocytic leukemia with single-agent arsenic trioxide.
about
Arsenic sulfide promotes apoptosis in retinoid acid resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET proteinArsenic trioxide induces apoptosis in human platelets via C-Jun NH2-terminal kinase activationArsenic trioxide and resveratrol show synergistic anti-leukemia activity and neutralized cardiotoxicityCardiac Glycosides Activate the Tumor Suppressor and Viral Restriction Factor Promyelocytic Leukemia Protein (PML)Metabolism, toxicity and anticancer activities of arsenic compounds.Synergistic inhibition of leukemia WEHI-3 cell growth by arsenic trioxide and Hedyotis diffusa Willd extract in vitro and in vivo.The Coadministration of N-Acetylcysteine Ameliorates the Effects of Arsenic Trioxide on the Male Mouse Genital System.Arsenic trioxide inhibits viability and induces apoptosis through reactivating the Wnt inhibitor secreted frizzled related protein-1 in prostate cancer cellsEmerging importance of dietary phytochemicals in fight against cancer: Role in targeting cancer stem cells.Tetra-arsenic tetra-sulfide (As4S 4) promotes apoptosis in retinoid acid -resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET protein.PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy.Severe Acute Axonal Neuropathy following Treatment with Arsenic Trioxide for Acute Promyelocytic Leukemia: a Case Report.E4-Ubiquitin ligase Ufd2 stabilizes Yap8 and modulates arsenic stress responses independent of the U-box motif.Arsenic trioxide exposure impairs testicular morphology in adult male mice and consequent fetus viability.Phenylarsine oxide (PAO) induces apoptosis in HepG2 cells via ROS-mediated mitochondria and ER-stress dependent signaling pathways.
P2860
Q28538642-18D0DC80-5E10-4546-B9CB-CCA3F2A50BEBQ28539034-606EA600-64DE-4E26-842A-B7DA3767C36DQ28542497-4FBB8D4A-21E1-4BC0-990D-02D278678B97Q30385919-0B50419F-9275-4B5B-946C-50FF4D803B36Q33618916-DB5B413B-2828-4CC4-ACBD-80F36BF4E8A2Q33744923-E4F756B5-3BA4-401B-BEF8-249FBC1C98D0Q36453805-E25641EF-56C9-46B0-AA01-17135FE01BD3Q36627473-D600C2E7-D044-4715-9DC4-4D4CD8E8EF28Q38725554-3AB9EEA8-A308-40CD-ADFF-DE34137D7C12Q39034077-A6F0B59D-6A08-4D47-9ADE-1EB912D96B03Q39805430-37E9E776-89F6-42EE-A135-909297F49053Q40720914-CF340AAD-F1E0-4E83-B5C6-53707B10FB69Q42639854-B7F21D1E-0F8A-4063-AB43-B231663E17ECQ47732235-B0BF8664-99B3-4C5D-8932-E738ECF17A3AQ47918806-93422F6B-F494-4F6E-823A-4E29691E6D71
P2860
Treatment of acute promyelocytic leukemia with single-agent arsenic trioxide.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Treatment of acute promyelocytic leukemia with single-agent arsenic trioxide.
@ast
Treatment of acute promyelocytic leukemia with single-agent arsenic trioxide.
@en
type
label
Treatment of acute promyelocytic leukemia with single-agent arsenic trioxide.
@ast
Treatment of acute promyelocytic leukemia with single-agent arsenic trioxide.
@en
prefLabel
Treatment of acute promyelocytic leukemia with single-agent arsenic trioxide.
@ast
Treatment of acute promyelocytic leukemia with single-agent arsenic trioxide.
@en
P2093
P2860
P356
P1476
Treatment of acute promyelocytic leukemia with single-agent arsenic trioxide.
@en
P2093
Alok Srivastava
Auro Viswabandya
Biju George
Ezhilarasi Chendamarai
Vikram Mathews
P2860
P304
P356
10.4084/MJHID.2011.056
P577
2011-11-28T00:00:00Z